4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-054675
Director sold 41,174 shares at an average $17.01 ($700,355)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SCHIFF ANDREW N Director | 2022-10-24 | Sale | −14,616 | $17.01 | $248,586 | 514,939 | I |
| SCHIFF ANDREW N Director | 2022-10-25 | Sale | −12,018 | $17.02 | $204,516 | 502,921 | I |
| SCHIFF ANDREW N Director | 2022-10-26 | Sale | −14,540 | $17.01 | $247,253 | 488,381 | I |
| Open-market sales · 41,174 sh · avg $17.01 · $700,355 | |||||||
Loading xslF345X03/doc4.xml…